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An evaluation of a multiplex PCR assay (Bruce-ladder) was performed in seven laboratories using 625
Brucella strains from different animal and geographical origins. This robust test can differentiate in a single
step all of the classical Brucella species, including those found in marine mammals and the S19, RB51, and
Rev.1 vaccine strains.
Brucellosis is caused by a facultative intracellular bacterium
of the genus Brucella, and it is one of the most frequent bac-
terial zoonoses in low-income countries, where the control
programs have not succeeded in eradicating this neglected
zoonosis. The disease is a major cause of direct economic
losses and an impediment to trade and exportation. The genus
Brucella consists of six recognized species, designated on the
basis of differences in pathogenicity and host preference: B.
melitensis (goats and sheep), B. abortus (cattle and bison), B.
suis (infecting primarily swine but also hares, rodents, and
reindeer), B. ovis (sheep), B. canis (dogs), and B. neotomae
(wood rats) (7). The discovery of Brucella in a wide variety of
marine mammals has led to the proposal of two new species: B.
ceti (cetaceans) and B. pinnipedialis (pinnipeds) (8). Some of
these species include several biovars, which are currently dis-
tinguished from each other by an analysis of approximately 25
phenotypic characteristics, including requirement for CO2,
H2S production, sensitivity to dyes and phages, and other met-
abolic properties (1). However, all these tests are time-con-
suming, require skilled technicians, and are not straightfor-
ward, and some reagents are not commercially available. In
addition, handling of this microorganism represents a high risk
for laboratory personnel, since most Brucella strains are highly
pathogenic for humans. Accurate diagnostic and typing proce-
dures are critical for the success of the eradication and control
of the disease, and therefore the identification of the different
species is of great epidemiological importance. In order to
overcome most of these difficulties, PCR-based assays have
been employed for molecular typing of Brucella species. How-
ever, one of the challenges of using DNA-based techniques for
differentiating the various Brucella species and strains is their
high degree of genetic homology (16). This article describes
the evaluation of a new multiplex PCR assay (10), named
Bruce-ladder, in seven different European laboratories. The
PCR protocol was standardized previously (10), and the same
protocol was used in all laboratories (see the supplemental
material). The selection of the DNA sequences to design the
PCR primers was based on species-specific or strain-specific
genetic differences (Table 1). Each laboratory used its own
Brucella strain collection, typed by standard bacteriological
procedures (1). A total of 625 Brucella strains were used (see
the complete list in the supplemental material). The collection
included the reference strains of all biovars of B. abortus, B.
melitensis, B. suis, and B. ovis, B. canis, B. neotomae, the B.
abortus S19, B. abortus RB51, and B. melitensis Rev.1 vaccine
strains, and the recently proposed B. pinnipedialis and B. ceti
(8). To ensure adequate diversity, isolates from different geo-
graphic origins and different animal species, including humans,
were selected (Table 2). Genomic DNA was extracted from
pure cultures by using standard microbial DNA isolation kits
or by heat lysis of bacterial cell cultures. Bruce-ladder identi-
fication was based on the numbers and sizes of seven products
amplified by PCR. A representative example of the multiplex
PCR result is presented in Fig. 1. PCR using DNA from B.
abortus strains amplified five fragments, of 1,682, 794, 587, 450,
and 152 bp in size; with B. melitensis DNA, an additional
1,071-bp fragment was amplified; and B. ovis was distinguished
by the absence of the 1,682-bp fragment and B. suis by the
presence of an additional 272-bp fragment (also present in B.
canis and B. neotomae). PCR with B. abortus S19 DNA did not
produce the 587-bp fragment common to all Brucella strains
tested, and B. abortus RB51 was readily distinguished by the
absence of the 1,682-bp and 1,320-bp fragments and by a spe-
cific additional 2,524-bp fragment. The B. melitensis Rev.1 vac-
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cine strain was readily distinguished from other B. melitensis
strains by a specific additional 218-bp fragment. B. canis was
distinguished by the absence of the 794-bp fragment and B.
neotomae by the absence of the 152-bp fragment. Finally, when
DNA from Brucella strains isolated from marine mammals (B.
pinnipedialis and B. ceti) was used, a specific additional
1,320-bp fragment was amplified whereas the 450-bp fragment
was absent. The same results presented in Fig. 1 were obtained
with all Brucella strains assayed, with the only exception being
some B. canis strains. Nine out of 21 B. canis strains showed
the same PCR profile as B. suis. Typing of these nine strains
was confirmed by classical typing and multiple-locus variable-
number tandem-repeat analysis (data not shown). Interest-
ingly, these B. canis strains with a B. suis-like profile were
resistant to basic fuchsin and safranin (a variant of the classical
B. canis phenotypic pattern). However, these findings do not
detract from the utility of the Bruce-ladder PCR, since it is
very simple, using sensitivity to dyes and phage susceptibility to
differentiate B. canis (a rough species) from B. suis (a smooth
species). In addition, B. canis is always isolated from dogs, and
B. suis has never been found in this host.
Although this PCR assay cannot differentiate among biovars
from the same species, Bruce-ladder was species specific and
all the strains and biovars from the same Brucella species gave
the same profile. The practical interest of Bruce-ladder for
typing purposes is evident since some of the cumbersome and
long-lasting microbiological procedures currently used could
be avoided. The specificity of the Bruce-ladder PCR has been
tested previously (10), using as targets DNA from 30 strains
phylogenetically or serologically related to Brucella. The
Bruce-ladder PCR worked equally well irrespective of the cul-
tural conditions, DNA extraction methods, or thermocyclers
used. The same results were obtained in seven different labo-
ratories with brucellae obtained from the five continents and
TABLE 1. Oligonucleotides used in Bruce-ladder multiplex PCR assay
Primera Sequence (5–3) Ampliconsize (bp) DNA target Source of genetic differences Reference(s)
BMEI0998f ATC CTA TTG CCC CGA
TAA GG
1,682 Glycosyltransferase, gene
wboA
IS711 insertion in BMEI0998 in
B. abortus RB51 and deletion
of 15,079 bp in BMEI0993–
BMEI1012 in B. ovis
9, 15
BMEI0997r GCT TCG CAT TTT CAC
TGT AGC
BMEI0535f GCG CAT TCT TCG GTT
ATG AA
450 (1,320)b Immunodominant
antigen, gene bp26
IS711 insertion in BMEI0535–
BMEI0536 in Brucella strains
isolated from marine mammals
5
BMEI0536r CGC AGG CGA AAA CAG
CTA TAA
BMEII0843f TTT ACA CAG GCA ATC
CAG CA
1,071 Outer membrane
protein, gene omp31
Deletion of 25,061 bp in
BMEII826–BMEII0850 in
B. abortus
17
BMEII0844r GCG TCC AGT TGT TGT
TGA TG
BMEI1436f ACG CAG ACG ACC TTC
GGT AT
794 Polysaccharide
deacetylase
Deletion of 976 bp in BMEI1435
in B. canis
13
BMEI1435r TTT ATC CAT CGC CCT
GTC AC
BMEII0428f GCC GCT ATT ATG TGG
ACT GG
587 Erythritol catabolism,
gene eryC (D-
erythrulose-1-
phosphate
dehydrogenase)
Deletion of 702 bp in
BMEII0427–BMEII0428 in
B. abortus S19
14
BMEII0428r AAT GAC TTC ACG GTC
GTT CG
BR0953f GGA ACA CTA CGC CAC
CTT GT
272 ABC transporter binding
protein
Deletion of 2,653 bp in BR0951–
BR0955 in B. melitensis and
B. abortus
11, 12
BR0953r GAT GGA GCA AAC GCT
GAA G
BMEI0752f CAG GCA AAC CCT CAG
AAG C
218 Ribosomal protein S12,
gene rpsL
Point mutation in BMEI0752 in
B. melitensis Rev.1
6
BMEI0752r GAT GTG GTA ACG CAC
ACC AA
BMEII0987f CGC AGA CAG TGA CCA
TCA AA
152 Transcriptional
regulator, CRP family
Deletion of 2,203 bp in
BMEII0986–BMEII0988 in
B. neotomae
13
BMEII0987r GTA TTC AGC CCC CGT
TAC CT
a Designation are based on the B. melitensis (BME) or B. suis (BR) genome sequences. f, forward; r, reverse.
b Due to a DNA insertion in the bp26 gene, the amplicon size in Brucella strains isolated from marine mammals is 1,320 bp.
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from humans and both domestic and wild animals (Table 2),
demonstrating without a doubt the reproducibility and robust-
ness of the PCR assay proposed.
One of the most popular PCR assays for the differentiation
of Brucella species, designated AMOS PCR (3), was based on
the polymorphism arising from species-specific localization of
the insertion sequence IS711 in the Brucella chromosome and
can differentiate B. abortus (biovars 1, 2, and 4), B. melitensis
FIG. 1. Differentiation of all Brucella species and S19, RB51, and Rev.1 vaccine strains by Bruce-ladder multiplex PCR. Lane 1 (A), B. abortus; lane
2 (M), B melitensis; lane 3 (O), B. ovis; lane 4 (S), B. suis; lane 5 (S19), B. abortus S19 vaccine strain; lane 6 (RB51), B. abortus RB51 vaccine strain; lane
7 (Rev.1), B. melitensis Rev.1 vaccine strain; lane 8 (C), B. canis; lane 9 (N), B. neotomae; lane 10 (Bp), B. pinnipedialis; lane 11 (Bc), B. ceti.
TABLE 2. Hosts and geographic origins of the 625 Brucella strains tested by Bruce-ladder PCR
Species Biovar Host(s) Origin
No. of
strains
tested
B. abortus 1 Cattle, buffalo, humans Spain, Portugal, France, Belgium, Brazil, USA,a Algeria 39
2 Cattle Costa Rica. Greece 3
3 Cattle, humans, sheep Spain, Portugal, France, Belgium, Greece 40
4 Cattle France, Italy, Equator 14
5 1
6 Cattle France 3
7 Cattle Mongolia, Turkey 2
9 Cattle Belgium, France 7
B. melitensis 1 Sheep, goats, cattle, humans Spain, Portugal, Belgium, USA, Mexico 45
2 Humans, goat, cattle Spain, Turkey, Lebanon 8
3 Sheep, goats, cattle, humans, swine, chamois Spain, Portugal, France, Belgium, Morocco, Croatia 163
B. suis 1 Wild boars, swine, hares, humans Croatia, China, United Kingdom, Portugal, France,
French Polynesia, Wallis and Futuna islands
25
2 Wild boars, swine, hares, humans, cattle Spain, Croatia, Portugal, Belgium, France, Germany 83
3 Wild boars, swine, horses, humans Croatia, Wallis and Futuna islands 10
4 Humans, caribou, musk oxen Canada 4
5 Human USA 1
B. ovis Sheep Spain, Croatia, France, Argentine, USA 25
B. canis Dogs Romania, Canada, Costa Rica, Madagascar, France,
Spain, Brazil, Serbia
21
B. neotomae 1
B. ceti Dolphins, whales, porpoises Scotland, Norway, Costa Rica, France 38
B. pinnipedialis Seals Scotland, Greeland Sea 27
B. abortus RB51 Cattle Spain, Portugal, USA 27
B. abortus S19 Cattle Spain, France, USA 3
B. melitensis Rev.1 Sheep, goats, cattle, humans Spain, France, South Africa, Portugal, Belgium, Israel,
USA
35
a USA, United States.
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(biovars 1, 2, and 3), and B. ovis and B. suis (biovar 1). Mod-
ifications of this assay have been introduced over the years to
improve performance, and additional strain-specific primers
were incorporated for identification of the B. abortus S19 and
RB51 vaccine strains (2, 4). However, other Brucella species
(such as B. canis, B. neotomae, B. pinnipedialis, and B. ceti) and
some particular biovars (B. abortus biovars 3, 5, 6, 7, and 9 and
B. suis biovars 2, 3, 4, and 5) cannot be detected by AMOS
PCR. A major advantage of the Bruce-ladder PCR assay over
previously described multiplex PCR tests is that it can identify
and differentiate for the first time all of the Brucella species
and the vaccine strains in the same test. In contrast to AMOS
PCR, Bruce-ladder PCR is also able to detect DNA from B.
canis, B. neotomae, Brucella isolates from marine mammals, B.
abortus biovars 3, 5, 6, 7, and 9, and B. suis biovars 2, 3, 4, and
5. Other advantages are speed (the PCR can be performed in
less than 24 h), minimal sample preparation (it works with
whole-cell lysates), and reduced risks (PCR can be carried out
with Brucella colonies, limiting the manipulation of live Bru-
cella). In conclusion, Bruce-ladder PCR can be a useful tool for
the rapid identification of Brucella strains of animal or human
origin, not only in reference centers but also in any basic
microbiology laboratory worldwide.
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